Skip to content
★ Sign in to follow
CS

Chanda Sikaria

Shareholder
Enveric Biosciences, Inc.
Total declarations
9
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€26k

Latest filing published 20 Nov 2018 for Enveric Biosciences, Inc., €480.

Insider track record

Disclosed buys
0
Disclosed sells
9
Signal history

Chanda Sikaria: trading record in brief

All filings by Chanda Sikaria on record concern Enveric Biosciences, Inc. The record holds 9 filings, all for trades on 16 November 2018.

The open-market record consists of 9 sales worth €26k, with no purchase.

The latest filing, published on 20 November 2018, reports an open-market sale of €480 in Enveric Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Chanda Sikaria

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations0 total
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    544 USD23SEC
    1,850 shares@ US$0.2941.8% of flowCommon StockSEC:0001607062-18-000436:7
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    17,243 USD29SEC
    58,850 shares@ US$0.29358.4% of flowCommon StockSEC:0001607062-18-000436:8
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    452 USD23SEC
    1,500 shares@ US$0.30111.5% of flowCommon StockSEC:0001607062-18-000436:1
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    455 USD23SEC
    1,515 shares@ US$0.30061.5% of flowCommon StockSEC:0001607062-18-000436:2
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    4,240 USD24SEC
    14,119 shares@ US$0.300314.3% of flowCommon StockSEC:0001607062-18-000436:3
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    4,575 USD25SEC
    15,251 shares@ US$0.3015.5% of flowCommon StockSEC:0001607062-18-000436:4
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    59 USD23SEC
    200 shares@ US$0.29510.2% of flowCommon StockSEC:0001607062-18-000436:5
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    1,964 USD24SEC
    6,657 shares@ US$0.2956.6% of flowCommon StockSEC:0001607062-18-000436:6
  • ▼
    10% OwnerExecutivesEnveric Biosciences, Inc.

    Same trade as the filing by Lokesh Sikaria Trust Dated 12/14/2012, counted once

    18 USD23SEC
    58 shares@ US$0.30280.1% of flowCommon StockSEC:0001607062-18-000436:0

9 of 0 declarations